XML 50 R38.htm IDEA: XBRL DOCUMENT v3.21.2
ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 02, 2021
USD ($)
$ / shares
Sep. 01, 2021
USD ($)
Jul. 31, 2021
USD ($)
Mar. 31, 2021
USD ($)
Feb. 28, 2021
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Business Acquisition [Line Items]                    
Payments to acquire productive assets                 $ 508,000,000 $ 472,000,000
Net sales             $ 3,226,000,000 $ 2,972,000,000 9,270,000,000 $ 8,492,000,000
Caelyx and Doxil                    
Business Acquisition [Line Items]                    
Payments to acquire productive assets           $ 325,000,000        
Net sales             32,000,000   73,000,000  
Customer Relationships | Caelyx and Doxil                    
Business Acquisition [Line Items]                    
Weighted-average useful life           8 years        
Payments to acquire productive assets           $ 11,000,000        
Developed Technology Intangible Asset | Caelyx and Doxil                    
Business Acquisition [Line Items]                    
Weighted-average useful life           9 years        
Payments to acquire productive assets           $ 314,000,000        
Bridge Facility                    
Business Acquisition [Line Items]                    
Debt instrument term     364 days              
364-day Senior Unsecured Bridge Term Loan | Bridge Facility                    
Business Acquisition [Line Items]                    
Senior notes     $ 11,400,000,000              
Period after which upfront fee will increase     120 days              
364-day Senior Unsecured Bridge Term Loan | Bridge Facility | Minimum                    
Business Acquisition [Line Items]                    
Upfront fee (percent)     $ 40,000,000              
364-day Senior Unsecured Bridge Term Loan | Bridge Facility | Maximum                    
Business Acquisition [Line Items]                    
Debt instrument term     364 days              
Upfront fee (percent)     $ 53,000,000              
Undrawn commitments ticking fee (percent)     0.125%              
364-day Senior Unsecured Bridge Term Loan | Bridge Facility | 90th day after initial funding | Maximum                    
Business Acquisition [Line Items]                    
Duration fee (percent)     0.50%              
364-day Senior Unsecured Bridge Term Loan | Bridge Facility | 180th day after initial funding | Maximum                    
Business Acquisition [Line Items]                    
Duration fee (percent)     0.75%              
364-day Senior Unsecured Bridge Term Loan | Bridge Facility | 270th day after initial funding | Maximum                    
Business Acquisition [Line Items]                    
Duration fee (percent)     1.00%              
Term Loan Credit Agreement | Term Loan Facility                    
Business Acquisition [Line Items]                    
Fees under the credit facilities (percent) 0.125%                  
Line of credit facility, maximum borrowing capacity $ 4,000,000,000           $ 4,000,000,000   $ 4,000,000,000  
Term Loan Credit Agreement | Term Loan Facility | First year                    
Business Acquisition [Line Items]                    
Loans annual amortization rate (percent) 0.625%           0.625%   0.625%  
Term Loan Credit Agreement | Term Loan Facility | After first year                    
Business Acquisition [Line Items]                    
Loans annual amortization rate (percent) 1.25%           1.25%   1.25%  
Term Loan Credit Agreement | Bridge Facility                    
Business Acquisition [Line Items]                    
Line of credit facility, accordion feature, decrease limit $ 7,400,000,000           $ 7,400,000,000   $ 7,400,000,000  
Three Year Term Loan | Term Loan Facility                    
Business Acquisition [Line Items]                    
Debt instrument term 3 years                  
Line of credit facility, maximum borrowing capacity $ 2,000,000,000           2,000,000,000   2,000,000,000  
Five Year Term Loan | Term Loan Facility                    
Business Acquisition [Line Items]                    
Debt instrument term 5 years                  
Line of credit facility, maximum borrowing capacity $ 2,000,000,000           $ 2,000,000,000   $ 2,000,000,000  
Five Year Term Loan | Term Loan Facility | After second anniversary                    
Business Acquisition [Line Items]                    
Loans annual amortization rate (percent) 1.875%           1.875%   1.875%  
Five Year Term Loan | Term Loan Facility | After third anniversary                    
Business Acquisition [Line Items]                    
Loans annual amortization rate (percent) 2.50%           2.50%   2.50%  
Hillrom                    
Business Acquisition [Line Items]                    
Cash consideration   $ 10,500,000,000                
Business​ combination​ consideration​ transferred   $ 12,400,000,000                
Acquire businesses, per share, cash paid (in dollars per share) | $ / shares   $ 156.00                
Glaxo Smith Kline | Transderm Scop                    
Business Acquisition [Line Items]                    
Business​ combination​ consideration​ transferred         $ 84,000,000          
Cash         60,000,000          
Contingent consideration         30,000,000          
Contingent consideration, fair value         24,000,000          
Glaxo Smith Kline | Transderm Scop | Developed Product Rights                    
Business Acquisition [Line Items]                    
Fair value of asset acquired         $ 64,000,000          
Weighted-average useful life         9 years          
Glaxo Smith Kline | Transderm Scop | Developed Product Rights | Measurement Input, Discount Rate                    
Business Acquisition [Line Items]                    
Discount rate used to measure intangible assets         0.225          
Glaxo Smith Kline | Transderm Scop | Customer Relationships                    
Business Acquisition [Line Items]                    
Fair value of asset acquired         $ 3,000,000          
Weighted-average useful life         7 years          
Glaxo Smith Kline | Transderm Scop | Customer Relationships | Measurement Input, Discount Rate                    
Business Acquisition [Line Items]                    
Discount rate used to measure intangible assets         0.155          
Cryo Life | PerClot                    
Business Acquisition [Line Items]                    
Business​ combination​ consideration​ transferred       $ 53,000,000            
Cash       25,000,000            
Contingent consideration       36,000,000            
Contingent consideration, fair value       28,000,000            
Cryo Life | PerClot | In Process Research and Development                    
Business Acquisition [Line Items]                    
Indefinite-lived intangible assets acquired       $ 39,000,000            
Cryo Life | PerClot | Measurement Input, Discount Rate | In Process Research and Development                    
Business Acquisition [Line Items]                    
Discount rate used to measure intangible assets       0.187            
Cryo Life | PerClot | Developed Product Rights                    
Business Acquisition [Line Items]                    
Fair value of asset acquired       $ 9,000,000            
Weighted-average useful life       10 years            
Cryo Life | PerClot | Developed Product Rights | Measurement Input, Discount Rate                    
Business Acquisition [Line Items]                    
Discount rate used to measure intangible assets       0.160            
Cryo Life | PerClot | Customer Relationships                    
Business Acquisition [Line Items]                    
Fair value of asset acquired       $ 1,000,000            
Weighted-average useful life       10 years            
Cryo Life | PerClot | Customer Relationships | Measurement Input, Discount Rate                    
Business Acquisition [Line Items]                    
Discount rate used to measure intangible assets       0.150